Wegener's Granulomatosis Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

TEMPO Study: Trimethoprim-Sulfamethoxazole in Granulomatosis With Polyangiitis
Conditions: Granulomatosis With Polyangiitis; Wegener Granulomatosis Intervention: Drug: Trimethoprim Sulfamethoxazole Sponsor: University of Pennsylvania Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2019 Category: Research Source Type: clinical trials

Plasma Exchange and Glucocorticoids for Treatment of Anti-Neutrophil Cytoplasm Antibody (ANCA) - Associated Vasculitis (PEXIVAS) - Glucocorticoids
Conditions: Granulomatosis With Polyangiitis (Wegener's) (GPA); Microscopic Polyangiitis (MPA) Interventions: Drug: Glucocorticoids - Standard Dose; Drug: Glucocorticoids - Reduced Dose Sponsor: University of Pennsylvania Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2019 Category: Research Source Type: clinical trials

Journey of Patients With Vasculitis From First Symptom to Diagnosis
Conditions: Vasculitis; Systemic Vasculitis; Behcet's Disease; CNS Vasculitis; Cryoglobulinemic Vasculitis; Eosinophilic Granulomatous Vasculitis; Temporal Arteritis; Giant Cell Arteritis; Granulomatosis With Polyangiitis; Wegener Granulomatosis; Henoch Schonlein Purpura; IgA Vasculitis; Microscopic Polyangiitis; Polyarteritis Nodosa; Takayasu Arteritis; Urticarial Vasculitis Intervention: Other: Online Questionnaire Sponsor: University of Pennsylvania Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 25, 2018 Category: Research Source Type: clinical trials